SCHEMBL20122430

SCHEMBL20122430

CC(=O)OCOC(=O)SC(C)(C)C(=O)N[C@@H](CS)C(=O)Oc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ACE P12821 4/20 0.33
▸ MME P08473 1/20 0.32
▸ ACE2 Q9BYF1 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ NFKB1 P19838 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ MTNR1A P48039 3/20 0.31
▸ MTNR1B P49286 3/20 0.31
▸ SIRT1 Q96EB6 1/20 0.31
▸ GAA P10253 2/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122423 0.91 ELANE (0.36) ATML3MBTL1ACEMMEACE2
SCHEMBL20122402 0.88 ATM (0.36) ATML3MBTL1THRBTDP1CYP1A2
SCHEMBL20122431 0.86 ALDH1A1 (0.43) MMEALDH1A1
SCHEMBL20122432 0.83 KDM4E (0.31) THRBNFKB1MAPT
SCHEMBL20122409 0.83 KDM4E (0.44) ACEMMEACE2THRBNFKB1
SCHEMBL20122429 0.81 CYP1A2 (0.33) L3MBTL1CYP1A2ALDH1A1CYP2C9CYP2C19
SCHEMBL20122434 0.81 — —
SCHEMBL20122428 0.80 — —
SCHEMBL20122578 0.79 ATM (0.35) ATML3MBTL1CYP1A2NFKB1NFKB2
SCHEMBL20122507 0.79 ELANE (0.35) ATML3MBTL1ACECYP1A2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback